Protective effects of NSAIDs on the development of Alzheimer disease
about
Shared molecular and functional frameworks among five complex human disorders: a comparative study on interactomes linked to susceptibility genesAspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's diseaseUse of ibuprofen and risk of Parkinson diseaseMicroglial Priming and Alzheimer's Disease: A Possible Role for (Early) Immune Challenges and Epigenetics?Targeting innate immunity for neurodegenerative disorders of the central nervous systemGenetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and TauopathiesMyeloid Dendritic Cells are Potential Players in Human Neurodegenerative DiseasesPotential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer's DiseaseNon-steroidal anti-inflammatory drugs and cognitive function: are prostaglandins at the heart of cognitive impairment in dementia and delirium?Diverse molecular targets for therapeutic strategies in Alzheimer's diseaseAntagonism of neuronal prostaglandin E(2) receptor subtype 1 mitigates amyloid β neurotoxicity in vitroThe airbag problem-a potential culprit for bench-to-bedside translational efforts: relevance for Alzheimer's diseaseViruses and neurodegenerationNeuroprotective and symptomatic effects of targeting group III mGlu receptors in neurodegenerative diseaseEnhanced longevity by ibuprofen, conserved in multiple species, occurs in yeast through inhibition of tryptophan importStress Granules Modulate SYK to Cause Microglial Cell Dysfunction in Alzheimer's Disease.NO2 inhalation promotes Alzheimer's disease-like progression: cyclooxygenase-2-derived prostaglandin E2 modulation and monoacylglycerol lipase inhibition-targeted medicationDoes neuroinflammation fan the flame in neurodegenerative diseases?Ageing, neurodegeneration and brain rejuvenationFriend or foe: the dichotomous impact of T cells on neuro-de/re-generation during agingThe Alzheimer pandemic: is paracetamol to blame?Short-term treatment with tolfenamic acid improves cognitive functions in Alzheimer's disease miceProstaglandin signaling suppresses beneficial microglial function in Alzheimer's disease models.Human neural stem cells alleviate Alzheimer-like pathology in a mouse model.The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy.Dementia Prevention: optimizing the use of observational data for personal, clinical, and public health decision-makingModulation of microglial innate immunity in Alzheimer's disease by activation of peroxisome proliferator-activated receptor gamma.Cyclooxygenase-1 null mice show reduced neuroinflammation in response to beta-amyloid.Omega-3 fatty acids and dementia.Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration.Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations.Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment.Intermittent fasting attenuates lipopolysaccharide-induced neuroinflammation and memory impairment.Voluntary Exercise Promotes Glymphatic Clearance of Amyloid Beta and Reduces the Activation of Astrocytes and Microglia in Aged Mice.In vivo evaluation of microglia activation by intracranial iron overload in central pain after spinal cord injuryWhy pleiotropic interventions are needed for Alzheimer's disease.Molecular dynamics simulations of anti-aggregation effect of ibuprofen.Presenilin/gamma-Secretase and Inflammation.Implications of gliotransmission for the pharmacotherapy of CNS disorders.CNS expression of anti-inflammatory cytokine interleukin-4 attenuates Alzheimer's disease-like pathogenesis in APP+PS1 bigenic mice
P2860
Q21135491-B20EB0E3-65C5-4F01-B333-0D9857995619Q24203739-546E48F6-EAE5-447F-9E7C-A444AE80F493Q24594751-430F83EB-9AD4-417C-9342-2F94B84F84EEQ26739495-A79B56CD-56DE-4AEA-B811-5EE7E188EFF9Q26744219-7732CD1B-0A30-4E24-894C-31130E48B064Q26767289-411E9264-8D21-46EA-B8B9-BA10C7AA7ABCQ26770676-DF8CFD02-4AF8-4839-B3D1-8970CD1E9383Q26783325-2034912B-51A8-4EB3-9D7B-93BD562BFA76Q26822022-E7D665A3-2A28-4EA4-ACC4-31B711F119AAQ26827193-D606CD44-60D7-407B-84B3-03DD720858C9Q26861848-5E7C0CF2-F747-4532-A33A-56932759E467Q26991654-7895FADC-F662-4FF4-A414-85F896763E53Q26991740-831C4C84-3AF9-4238-862D-C62F5EA47777Q26995351-00ADBB87-F63F-4525-AE63-7968FB26100AQ27311613-969BC7C7-98E3-4FA2-93C3-9032C5F941E3Q27311810-3D6B8AFF-18E3-4444-B3DA-BF0288AA853FQ27334947-B1261517-C378-45C6-BDF8-9A0EE7F4E5BDQ27498993-47B5E8E2-1C0D-4D7E-8F09-59CD5400155AQ28071590-461E6FC4-E971-4019-B286-20CA0B4AF136Q28077869-E78164A4-0A48-45DB-9ADF-5878B52FC9E0Q30357019-E35F69F1-F2CD-4320-9FA6-79C1C1D16816Q30541295-C400674B-A2C2-4AB0-80B2-C429F99A50C0Q30634663-DDCEEB1C-2A60-40F5-B4C3-E351CC94C9C8Q30662068-B7CBBFAF-48E0-4BEE-BB6E-AF09483745B9Q30668465-33FF7F87-F217-4C45-8065-ADB21544D9C5Q30978649-36A7AFBE-81B6-45E8-9210-8F5ACC80D9EFQ33575523-42DFF83D-FC55-4AC8-9A87-ADAC979346ABQ33588687-B225FE69-6A5E-4F53-9DC9-0F551FEBDCFBQ33602402-BDD21D70-5F49-4858-A1ED-05BFCD16ED26Q33603263-79139C49-100E-4F0B-8CB3-B1C6F64805E5Q33624653-CF9BA3B3-92E2-4023-B466-80EB0F5CB881Q33626656-ECC07BEC-83A5-47B1-A2E9-827A43EE17FBQ33696681-0F51CE02-7958-4BFC-8438-CAB2C78306F0Q33705067-FA2BA960-5B31-4EED-8FD8-E1A13CBB9EBCQ33706685-A51C4D43-3581-47CF-8D34-604E7BBDDF0AQ33876128-546101DE-6E27-4952-8E5C-DD29D0CF2B28Q33880238-D533847F-145C-4FC2-8E4A-C87537152875Q33918695-9135D210-2DF5-41EA-9189-A78B34398CC4Q33971765-77F1B0F1-38FB-4D02-95B2-C9BF667919DBQ34017180-15710B9C-DAAA-42CC-BA3B-383922C4F239
P2860
Protective effects of NSAIDs on the development of Alzheimer disease
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Protective effects of NSAIDs on the development of Alzheimer disease
@ast
Protective effects of NSAIDs on the development of Alzheimer disease
@en
Protective effects of NSAIDs on the development of Alzheimer disease
@nl
type
label
Protective effects of NSAIDs on the development of Alzheimer disease
@ast
Protective effects of NSAIDs on the development of Alzheimer disease
@en
Protective effects of NSAIDs on the development of Alzheimer disease
@nl
prefLabel
Protective effects of NSAIDs on the development of Alzheimer disease
@ast
Protective effects of NSAIDs on the development of Alzheimer disease
@en
Protective effects of NSAIDs on the development of Alzheimer disease
@nl
P2860
P3181
P1433
P1476
Protective effects of NSAIDs on the development of Alzheimer disease
@en
P2093
Neil W Kowall
Steven C Vlad
P2860
P304
P3181
P356
10.1212/01.WNL.0000311269.57716.63
P407
P577
2008-05-06T00:00:00Z